Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia

ClinicalTrials.gov ID: NCT02282215

Public ClinicalTrials.gov record NCT02282215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Phase 2 Prospective, Randomized, Controlled Study of CLT-008 Myeloid Progenitor Cells as a Supportive Care Measure During Induction Chemotherapy for Acute Myeloid Leukemia

Study identification

NCT ID
NCT02282215
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cellerant Therapeutics
Industry
Enrollment
163 participants

Conditions and interventions

Interventions

  • CLT-008 Biological
  • G-CSF Biological

Biological

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2014
Primary completion
Sep 21, 2017
Completion
Sep 21, 2017
Last update posted
Sep 26, 2018

2014 – 2017

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
University of California San Diego Moores Cancer Center La Jolla California 92093
Ronald Reagan UCLA Medical Center Los Angeles California 90095
University of California, San Francisco Medical Center San Francisco California 94143
UF Health Shands Cancer Hospital Gainesville Florida 32608
Mayo Clinic Florida Jacksonville Florida 32224
Northside Hospital Atlanta Georgia 30342
Northwestern Medical Faculty Foundation Chicago Illinois 60611
University of Illinois Cancer Center Chicago Illinois 60612
The University of Chicago Chicago Illinois 60637
Loyola University Medical Center Maywood Illinois 60153
Indiana Blood and Marrow Transplantation Clinic Indianapolis Indiana 46237
University of Massachusetts Worcester Worcester Massachusetts 01655
University of Minnesota Physicians BMT Clinic Minneapolis Minnesota 55455
Kansas City Veterans Affairs Medical Center Kansas City Missouri 64128
Washington University School of Medicine St Louis Missouri 63110
Weill Cornell Medical College - New York Presbyterian Hospital New York New York 10065
Memorial Sloan Kettering Cancer Center New York New York 66215
Westchester Medical Center Valhalla New York 10595
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
West Penn Hospital Pittsburgh Pennsylvania 15224
The University of Texas MD Anderson Cancer Center Houston Texas 77030
Swedish Cancer Institute Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02282215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02282215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →